scott lewis

[scott lewis @ScottLewis43]

🔇裸聊 🚁喷水 🚟精厕 💓足交 🩸指挥 🤘洗脑 📲群P 🦇cos 🍍聊天 🦑出卖 🏯榨汁机 🦟女王 🦈云顶之奕 ⬇网调 🍝娇喘 😷女铲 ⛽红绿灯 🏦贱M 🍨91视频

[scott lewis @ScottLewis43]

@Womenstea

[scott lewis @ScottLewis43]

@4up2date I’ll beat it up…

[scott lewis @ScottLewis43]

@Sophiascuups I’m Cracking…

[scott lewis @ScottLewis43]

Rerum doloribus qui alias reiciendis.

[Valerie Anne Smith @ValerieAnne1970]

🚨THEY BURIED THIS FOR A REASON:

Hydroxychloroquine doesn’t just block viruses — it reprograms them into cancer hunters that zero in on tumor cells while leaving healthy ones untouched.

One of America's Frontline Doctors, Dr. Richard Urso exposes the truth. The real question: why was every trace of this research suppressed and ridiculed?

A dirt-cheap, decades-old drug that could selectively destroy cancer would obliterate the multi-trillion-dollar oncology cash machine overnight.

They don’t want cures. They want lifetime customers paying for toxic chemo, radiation, and “new” drugs that cost hundreds of thousands.

This information was deliberately buried.
The truth is leaking out again.

[scott lewis @ScottLewis43]

@putzisbackbaby

[scott lewis @ScottLewis43]

@StarwearUS

[Massimo @Rainmaker1973]

A 30 percent vitamin C solution dissolved in DMSO cleared 86 percent of basal cell skin cancer lesions within eight weeks in a clinical trial. In a randomized study published in Biomedicine & Pharmacotherapy, researchers tested a topical mix of high-concentration ascorbic acid and dimethyl sulfoxide, a solvent that helps substances penetrate deeply into the skin.

Applied twice daily for eight weeks, the combination produced complete clearance in 13 of 15 lesions (86.7 percent) among patients with low-risk basal cell carcinoma. This rate exceeded that of the standard topical treatment imiquimod, which cleared 8 of 14 lesions (57.1 percent). The vitamin C–DMSO formulation also caused fewer side effects and avoided the lasting skin hypopigmentation sometimes seen with conventional topical therapies.

Because basal cell carcinoma is the most common form of skin cancer worldwide, these early results suggest a possible low-cost, non-invasive option. Larger trials are still required before the approach can be adopted as standard care.

[Burke, B., & Bailie, J.-E. (2022). Randomized trial of topical ascorbic acid in DMSO versus imiquimod for the treatment of basal cell carcinoma. Biomedicine & Pharmacotherapy, 148, 112710. DOI: 10.1016/j.biopha.2022.112710]

[scott lewis @ScottLewis43]

@CowboyFL2 @olivegarden

[scott lewis @ScottLewis43]

@digitalassetbuy

[scott lewis @ScottLewis43]

@usglogisti12914

[scott lewis @ScottLewis43]

@trend_kill420

[scott lewis @ScottLewis43]

@almondluvr06

[scott lewis @ScottLewis43]

@Headshok1962 He’s must be telling lies

[scott lewis @ScottLewis43]

@Flowryyy_ @tymboyszn 181. You have to put the stick you remove somewhere else

[scott lewis @ScottLewis43]

@itsnoradavis We Crackin’

[scott lewis @ScottLewis43]

@usuallypregnant

[scott lewis @ScottLewis43]

@GrayChateau Crack the whole family tree